Pfizer close to off-patent drug combo with Mylan - Pfizer Inc. (NYSE:PFE) | Seeking Alpha: Pfizer (PFE) is close to a deal to combine its off-patent drugs business with Mylan (MYL), The Wall Street Journal reports. That would build a giant of low
explicita
Sem comentários:
Enviar um comentário